Conflict of interest register: Clinical Practice ... · Last updated: June 2018. Page 1 Conflict of interest register: Clinical Practice Guidelines for the Diagnosis and Management

Last updated: June 2018. Page 1

Conflict of interest register:

Clinical Practice Guidelines for the Diagnosis and Management of Melanoma

Management Committee members

Name Position Relevant financial activities Relevant professional and organisational experience Other relationships or

activities

Professor

John

Thompson

Executive Director,

Melanoma Institute

Australia

Consultancy fees/ honorarium

Honoraria received from GlaxoSmithKline,

Bristol Myers Squibb, Provectus and Merck

Sharp Dohme

Support for travel or accommodation

Travel support received from

GlaxoSmithKline, Bristol Myers Squibb and

Provectus

Publications

See attachment A1.

Speeches/lectures See attachment A1.

Development of related materials, including guidelines, standards, educational materials or fact sheets Chairman of previous Working Party for Clinical Practise

Guidelines for the Management of Cutaneous Melanoma in

Australia and New Zealand

Honorary Roles See attachment A1.

None.

Professor

Michael

Henderson

Professor of Surgery,

University of Melbourne;

Co-Chair, Melanoma and

Skin Service, Peter

MacCallum Cancer Centre

None. None. None.


Professor John

Kelly

Dermatologist, Victorian

Melanoma Service, Alfred

Health, Melbourne

Ownership interests

Superannuation fund owns shares in

MoleMap Australia PL. Personal shares in

MoleMap Australia since 2005.

Publications

See attachment A2.


Expert Testimony

Medicolegal opinions provided.

Development of related materials, including guidelines, standards, educational materials or fact sheets Melanoma Clinical Pathway.

Pathology Reporting Expert Group.

Cancer Council Melanoma Booklet.

None.

Other

See attachment A2.

Professor

Georgina

Long

Medical oncologist,

Melanoma Institute

Australia; Professor of

Melanoma Medical

Oncology and Translational Research (MIA, University of Sydney, Mater and Royal North Shore

Hospitals), NSW


BMS, Novartis, Roche, Amgen, Pierre Fabre,

MERCK and Array


BMS, Novartis, Roche, Amgen, Pierre Fabre,

MERCK and Array

Other (e.g. registration fees for conferences, institutional interests, etc – see policy) BMS, Novartis, Roche, Amgen, Pierre Fabre,

MERCK and Array

Publications

See attachment A3.


Development of related materials, including guidelines, standards, educational materials or fact sheets See attachment A3.

None.


A/Professor

Susan

Neuhaus

General Surgeon and

Surgical Oncologist, Royal

Adelaide Hospital; Clinical

Associate Professor,

University of Adelaide

Department of Surgery;


Conflict Medicine,

University of Adelaide, SA


Previous Guideline meetings

Meals and beverages

Previous Guideline meetings

Publications

See attachment A4.

Speeches/lectures

See attachment A4.


Unpaid advisory roles

RACS Examiner

None.

Dr Annette

Pflugfelder

PhD Student, Dermatology

Research Centre, School of

Medicine, The University of

Queensland

None. Publications

See attachment A5.

Speeches/lectures

Related to German Melanoma Guideline.

Development of related materials, including guidelines, standards, educational materials or fact sheets Development of German Guideline for melanoma patients.

None.

Professor

Richard

Scolyer

Clinical Professor,

Pathology, Central Clinical

School

None. Publications

See attachment A6.

Speeches/lectures

None.

See attachment A6.

Professor

Graham

Stevens

Director of Radiation

Oncology; Professor

Radiation Oncology

None. Publications

Oxford Textbook of Melanoma.

Development of related materials, including guidelines,

standards, educational materials or fact sheets

Previous Melanoma Guideline.

None.

Ms Jutta von

Dincklage

Head, Clinical Guidelines

Network (until November

2016)

Employment

Head, Clinical Guidelines Network, Cancer

Council Australia

None. None.


Ms Laura

Wuellner

Acting Head, Clinical

Guidelines Network (until

November 2016)

Employment

Acting Head, Clinical Guidelines Network,

Cancer Council Australia

None. None.

Section Leaders

Name Position Relevant financial activities Relevant professional and organisatio nal experience Other relationships or

activities

A/Professor

Andrew

Barbour

General Surgeon,

Greenslopes Private

Hospital, Princess

Alexandra Hospital, QLD

None. None. None.

Dr Matteo

Carlino

Medical Oncologist

Westmead and

Blacktown Hospitals,

Melanoma institute Australia Clinical Senior lecturer University of Sydney

Consultancy fees/honorarium:

Board member Bristol Myers Squibb, MSD,

Novartis

Travel support and registration fees from

Bristol Myers Squibb & MSD

Publications; speeches and lecture

attachment A7.

See None.

Dr David

Gyorki

Consultant Surgeon, Peter

MacCallum Centre

None. Publications

See attachment A8.

None.

A/Professor

Angela Hong

Radiation Oncologist,

Melanoma Institute

Australia; Clinical



Sydney


Publications

Not specified.

Speeches/lectures Not specified.

None.


Dr Julie Howle Clinical Senior Lecturer,

Surgery, The University of

Sydney; Surgeon,

Westmead Hospital

None. Publications Not

specified.

Speeches/lectures Not

specified.

A/Professor T

Michael

Hughes

Associate Professor in

Surgery, The University of

Sydney; Surgeon, Sydney

Adventist Hospital

Employment

Surgical oncologist.

Ownership Interests

Owns a surgical oncology practise.

Publications Not

specified.


specified.

Relationships

Associate of M.I.A.

Professor

Richard

Kefford AM

Professor of Cancer

Medicine, Macquarie

University


Support for conference attendance; Bristol

Myers Squibb, Merck

Registration fees for conferences

Bristol Myers Squibb, Merck

Paid advisory boards

Bristol Myers Squibb, Merck, Amgem, Novartis, Tera

None.

Professor

Graham Mann

Chair, University of Sydney Cancer Research Network and Cancer MDI Co-

Director, Centre for

Cancer Research,

Westmead Institute of

Medical Research Chair,

Research Committee,

Melanoma Institute

Australia, University of

Sydney.

Employment

University of Sydney.

Grants

Benefits received or expected: NHMRC,

NSW Govt (OHMR), CINSW, Cancer

Council NSW, ARC, ACRF, University of

Sydney


NHMRC

Support for travel or accommodation,

Meals and/or beverages

NHMRC

Publications

See Attachment A9.

Speeches/lectures

Reviews of evidence, including outcomes of own and

collaborative research, multiple forums

Expert testimony

Australian Parliamentary Enquiry into Skin Cancer 2014

Development of related materials, including guidelines, standards, educational materials or fact sheets 2010 NHMRC Guidelines on Melanoma; Information guides – e.g. CV ref 65 (attachment A9)

None.


Dr Victoria Mar Dermatologist and Director,

Victorian Melanoma

Service, Alfred Health,

Melbourne

None. Publications

See Attachment A10.

Speeches/lectures See

Attachment A10.

Development of related materials, including guidelines,

standards, educational materials or fact sheets

None.

See Attachment A10.

Professor

Scott Menzies

The Sydney Melanoma

Diagnostic Centre, Royal

Prince Alfred Hospital;

Professor, Discipline of

Dermatology, The

University of Sydney

Employment

See attachment A10.

Ownership interests

Board membership

Grants


Publications

See attachment A11.

Speeches/lectures

See attachment A11.

Expert Testimony

See attachment A11.



Not specified.

None.


Professor

Michael

Millward

Professor of Clinical

Cancer Research, The

University of Western

Australia; Consultant

Medical Oncologist, Sir

Charles Gairdner Hospital

Grants

Conducted multiple clinical trials in melanoma

which has resulted in payments to

departments/institutions associated with Professor Michael Millward’s. The entities

involved include Bristol-Meyers Squibb, Glaxo-

Smith Kline, Novartis, Merck, Sharp & Dohme, Roche. No personal remuneration was

received for these activities.


Member of pharmaceutical advisory boards relating to the treatment of melanoma. Entities involved include Bristol-Meyers Squibb, Glaxo-Smith Kline, Merck, Sharp & Dohme, Roche, Amgem, Provectus.

Support for travel or accommodation Received travel and accommodation support for pharmaceutical advisory board roles above.

Meals and beverages

Received meals and beverages in accordance with Medicines Australia Guidelines for pharmaceutical advisory board roles above.

Registration fees for conferences

Publications

See attachment A12.


Development of related materials, including guidelines, standards, educational materials or fact sheets Development of education materials, information for the consumers related to the management of melanoma.


Provided advice to various bodies related to management of melanoma and the care of melanoma patients.

Relationships

See Attachment A12.

Received support to attend conferences

related to the activities above.


Dr Rachael

Morton

Director of Health

Economics, NHMRC

Clinical Trials Centre, The


Grants

Benefits received or expected: NHMRC,

Cancer Australia, CINSW, Cancer Council

NSW, University of Sydney


NHMRC

Support for travel or accommodation,

Meals and/or beverages

NHMRC

Publications

See attachment A13.

Speeches/lectures

See attachment A13.

Development of related materials, including guidelines, standards, educational materials or fact sheets Developed a Melanoma information booklet for use in a

RCT of psychoeducational support for people at high risk

of melanoma.

None.

Dr Robyn Saw Senior Lecturer, Surgery,

The University of Sydney;

Surgical Oncologist;

General Surgeon,

Melanoma Institute

Australia and Royal Prince

Alfred & Mater Hospitals

Consultancy fees/honorarium

Amgem and Bristol Myers Squibb


Amgem

Publications

See Attachment A14.

Speeches/lectures

See Attachment A14.

Development of related materials, including guidelines, standards, educational materials or fact sheets See Attachment A14.

Other

See attachment A14.

Dr Brindha

Shivalingam

Director of Neurosurgery,

The Chris O’Brien

Lifehouse; Consultant

Neurosurgeon, Royal

Prince Alfred Hospital and

The Mater Hospital North

Sydney

None. Publications

See Attachment A15

Speeches/lectures

Not specified

Expert testimony

Not specified

Development of related materials, including

guidelines, standards, educational materials or fact

sheets

None.


Not specified

A/Professor

Michael

Sladden

Dermatologist, Tas Derm None. Publications None.

See attachment A16.

ated materials, including guidelines,

onal materials or fact sheets

melanoma excision margins.

Development of rel standards, educati Cochrane review on

Professor H.

Peter Soyer

Director, School of

Medicine, University of

Queensland; Director,

Dermatology Department,

Princess Alexandra

Hospital

Board membership Publications None.

See attachment A38.

Canfield Scientific (SA); Molemap

Australia

See attachment A38.

ated materials, including guidelines,

onal materials or fact sheets

See

Grants

Speeches/lectures

See attachment A38. See attachment A38.

Consultancy

fees/honorarium

Greenslopes Private Hospital (Qld,

AUS);

Development of rel

standards, educati

See attachment A38.

Other (e.g. unpaid advisory

roles)

attachment A38.


Support for travel or accommodation specified.

Meals and beverages specified.

Entertainment, gifts or gratuities specified.

Oher (e.g.

see policy)

Not specified.

Not

Not

Not

registration feeds for

conferences, institutional interests, etc –


A/Professor

Andrew

Spillane


Surgical Oncology, The

Unversity of Sydney;

Surgical oncologist,


Invited speaker ABS Breast Cancer

Conference 2015 Airfares and

Accommodation paid by ABS

Publications

See attachment A17.

Speeches/lectures

See attachment A17.


None.

Dr Alex Varey Staff Specialist,

Department of Plastic and

Maxillofacial Surgery,

Westmead Hospital,

Sydney, Australia

None.

Publications

See attachment A34.

Speeches/lectures

See attachment A34.

Development of related materials, including

guidelines, standards, educational materials or fact

sheets

Relationships

See attachment A34.

Activities

See attachment A34.

See attachment A34.

Consumers

Name Position Relevant financial activities Relevant professional and organisational experience Other relationships

or activities


Ms Alison

Button-Sloan

Consumer Employment

Employed as a Registered Nurse and Diabetes Educator in General Practice. Also assist General Practitioners with skin checks and skin excisions/biopsies.

Support for travel or accommodation All provided by Melanoma Patients Australia (MPA):

Attended launch of MPA's KPMG

commissioned report 'Advanced

Other

Review research proposals from the ANZMTG and other researchers from a consumer perspective forwarded by Project Manager for the Melbourne Melanoma Project (MMP)

Write articles of interest for MPA's National Support Group Facilitators' Newsletter quarterly.

Relationships

Member/consumer

representative of the following organisations:

Melanoma Patients

Australia

(MPA)

Cancer Council

Victoria (CCV)

Melbourne

Melanoma Project -

Consumer

Reference Group

Melanoma – The real cost of

Australia's national cancer' at

Parliament House. Return economy

flights Melbourne to Canberra.

One-night accommodation. Attended MPA annual gala dinner committee meetings in Brisbane. Car hire for 3days.

Attended the MPA Annual Gala and Awards Dinner as organiser. Return economy flights Melbourne to Brisbane.

One-night accommodation.

Meals and Beverages

Meals and beverages provided by MPA at events above.

Other

Sponsored by MPA to attend

Clinical Oncology Society of Australia

Annual Scientific Meeting Conference.

(MMP-CRG)

Australian

Melanoma

Consumer

Alliance (AMCA)

Activities

Facilitator for

monthly MPA

Support

Group Meetings in

Melbourne.


Mr Clinton Heal Consumer, CEO and

Founder, Melanoma WA;

2011 WA Young

Australian of the Year

Employment

CEO of Melanoma WA

Board membership

Board member of WAMAS WA

Melanoma Health study and AMCA.

Support for travel or

accommodation

Support (flights) to attend Guideline meetings.

Publications

WA Medical Forum.

Speeches/lectures

Community forums, Media and Speaking engagements.

Expert Testimony

National Skin cancer inquiry.

Development of related materials, including guidelines, standards, educational materials or fact sheets

Previous involvement in ‘Understanding Melanoma’ publication.


Board member of WAMAS WA Melanoma health study.

None.


GP representatives

Name Position Relevant financial activities Relevant professional and

organisational experience

Other relationships

or activities

Dr Margaret

Hardy

General practitioner MSD's GP Advisory Committee on Insomnia (disclosed

because MSD produce a product for melanoma)

None. None.

Dr Paul

Fishburn

General practitioner None. None. None.

Cancer Council Australia Staff Members

Name Position Relevant financial activities Relevant professional and


Other relationships or

activities

Ms Laura Wuellner Project Manager Clinical Guidelines

Network (until November 2016); Acting

Head, Clinical Guidelines Network (from

November 2016)

Employment

Project Manager Clinical Guidelines Network,


None. None.

Ms Katrina Anderson Project Manager Clinical Guidelines

Network (from November 2016)

Employment

Project Manager Clinical Guidelines Network,


None. None.

Ms Jackie Buck Project Officer, Clinical Guidelines Network

(until April 2016)

Employment

Project Officer Clinical Guidelines Network,


None. None.

Ms Lani Teddy Project Officer, Clinical Guidelines Network

(until December 2016)

Employment



None. None.

Ms Lyndal Alchin Project Officer, Clinical Guidelines Network

(until December 2016)

Employment



None. None.


Ms Tamsin Parrish Project Officer, Clinical Guidelines Network

(from June 2016 until December 2017)

Employment



None. None.

Ms Cecilia Taing Project Officer, Clinical Guidelines Network

(from January 2017)

Employment



None. None.

Ms Meghna Kakani Project Officer, Clinical Guidelines Network

(from January 2017)

Employment



None. None.

Subcommittee members

Name Position Relevant financial activities

Relevant profess ional and


Other relationships or

activities

Dr Nikki Adler Clinical Fellow, The Alfred

Hospital

None. Publications

Adler NR, Haydon A, McLean

C, Kelly JW & Mar V J.

Metastatic pathways in

patients with cutaneous mela

noma. oma Pigment Cell

Melan Res 2016; 30: 13-27.

Activities

I am currently employed as a

Clinical Fellow at the Victorian

Melanoma Service, The Alfred

Hospital, Melbourne, Australia.

Dr Victoria Atkinson Senior Medical Oncologist,

Princess Alexandra Hospital


Advisory boards of MSD,

Novartis, Bristol Myers Squibb,

Merck Serono, Pierre Fabre

Support for travel or accommodation Bristol Myers Squibb

Publications

See Attachment

A18

None.


Dr Trevor Beer Dermatopathologist, Clinipath

Pathology

None. Publications

See Attachment

A19

Speeches/lectures

ated g

ds,

Development of rel als or fact

materials, includin

guidelines, standar

See Attachment

A19

Relationships

See Attachment A19

Activities

See Attachment A19

educational materi

sheets

See Attachment A19

Dr Friyana Bhabha None. None. None.

Dr Michael Brown Medical oncologist, Royal

Adelaide Hospital


Melanoma Advisory Boards for

GSK, BMS, Roche Prostate

Cancer

None. None.

Advisory Board for Bayer

Research support from Novartis

Support for travel or

accommodation

Travel sponsorship from Eli Lilly

Educational grant from BMS

Dr Frank Bruscino-Raiola Director, Plastic, Hand & None. See None.


Faciomaxillary Surgery Unit,

The Alfred Hospital

Speeches/lectures

attachment A39.

Prof Bryan Burmeister Director of Radiation Oncology,


None. None. None.

Dr Alex Chamberlain Dermatologist, The Alfred Hospital Consultancy fees/honorarium

La Roche Posay/L’Oreal


La Roche Posay/L’Oreal

Publications

Mar V, Chamberlain A, Kelly J, Murray W, Thompson JF. Diagnosing melanomas that lack the classifical clinical features. MJA 2017; 207(8):34850. Kelly JW, Adler N, Guitera P,

Menzies SW, Chamberlain AJ,

Heal C, Soyer HP. New

Australian Clinical Practice

Guidelines for the Diagnosis and Management of Melanoma. MJA 2018 (in press).

Speeches/lectures

Tasmanian Melanoma Forum for GPs 2016, Launceston, Hobart; RACGP Dermatology in General Practice Update,

Melbourne Convention Centre

2017

Expert testimony

Avant P/L – Medicolegal report

None.

Dr Svetlana Cherepanoff Consultant Pathologist &

Leader, Ophthalmic Pathology

Research Group, Brain and

Mind Centre, The University of

Sydney

None. Speeches/lectures See

attachment A20.

Development of related

materials, including guidelines,

standards, educational

materials or fact sheets

None.

Development of stru ctured

macroscopic and mi croscopic

reporting protocols f or ocular


melanoma at my hospital

A/Prof Max Conway Associate Professor, Clinical

Opthalmology & Eye Health,

Central Clinical School, Save

Sight Institute

None. Publications

See Attachment

A21

Speeches/lectures

Many (not specified)

Expert testimony ated One

(not specified) g

ds, als or

Development of rel act

materials, includin

guidelines, standar educational materi sheets Previous guideline

None.

Dr Rachel Conyers None. None. None.


A/Prof Brendon Coventry Associate Professor,

Department of Surgery, The

University of Adelaide; Senior

Consultant Surgeon, Royal

Adelaide Hospital

None. Publications

See Attachment

A31


Expert testimony

Not specified. ated

g

Development of rel ds,

materials, includin als or fact

guidelines, standar educational materi sheets

Not specified. advisory

Other (e.g. unpaid

roles)

Not specified.

Relationships

Australasian & American

College of Surgeons

Activities

Opinions

Dr Anne Cust Senior Research Fellow

Public Health, School of Public

Health, The University of

Sydney

Grants

I have received NHMRC & NIH

grants related to melanoma.

These were peer reviewed grants.

Publications

See Attachment

A22

Speeches/lectures

None.

See Attachment A22


Prof Diona Damian Professor of Dermatology,

Central Clinical School, The


None. Publications

See Attachment

A23

Speeches/lectures

See Attachment

A23

Development of rel materials, includin guidelines, standar ated

educational materi g

sheets

ds,

als or fact

Other (e.g. unpaid

roles) advisory

See Attachment

A23

None.

See Attachment A23

Dr Gerald Fogarty Director of Radiation Oncology,

Mater Hospital; Clinical

Associate Professor of


Sydney

None. Publications

See Attachment

A24

None.

Dr Michael Giblin Clinical Senior Lecturer, Clinical

Opthalmology & Eye Health,

Central Clinical School

None. None. None.


A/Prof Pascale Guitera Senior Research Fellow,

Dermatology, Central Clinical

School, The University of

Sydney


specified.


Expert testimony Not specified.

Development of rel materials,

includin guidelines, standar

ated educational materi g

sheets ds, als or

Not specified. act

None.

A/Prof Alexander Guminski Associate Professor


Sydney; Medical Oncologist,

Melanoma Institute Australia,

North Shore Private Hospital, and

Royal North Shore Hospital

Dr Mark Hanikeri Director, Western Plastic

Surgery Centre

Australia Employment

Clinical director of Western

Australian Kirkbride Melanoma

Advisory Service (and Western

Australian Melanoma Advisory

Service)

Publications

See Attachment

A25

Speeches/lectures

See Attachment

A25

Development of rel materials, includin guidelines, standar educational materi sheets See Attachment

A25

Other (e.g. unpaid

roles)

ated

g

ds,

als or fact

advisory

Relationships

Clinical director of Western

Australian Kirkbride Melanoma

Advisory Service

See Attachment A25


Dr Andrew Haydon Medical Oncologist, Alfred

Hospital and Cabrini Health


Not specified.

Support for travel or accommodation Not specified.

Publications Not

specified.



Not specified.

None.

Dr Craig James Pathologist, Adelaide Pathology

Partners

None. Publications

See Attachment A26

Speeches/lectures

See Attachment A26

Expert testimony

Not specified

Development of related materials, including guidelines, standards, educational materials or fact sheets Not specified

Other (e.g. unpaid advisory

roles) Not specified

None.

A/Prof Kiarash Khosrotehrani Group Leader, Experimental

Dermatology Group, UQ Centre

for Clinical Research, The

University of Queensland


specified.


specified.

None.


Dr Wenyuan Liu Dermatologist, Alfred Hospital,

Peter MacCallum Cancer

Centre, Victorian Melanoma

Service

Prof Grant McArthur Head, Molecular Oncology

Laboratory and Translational

Research Laboratory, Co-Chair,

Melanoma and Skin Service,


Centre

Employment


Centre

Victorian Comprehensive

Cancer Centre

University of Melbourne

Grants

See Attachment A37

Support for travel or accommodation See Attachment A37

Meals and beverages

See Attachment A37

Other (e.g. registration fees

for conferences, instutitional

interest etc – see policy)

Publications

See Attachment A37

Speeches/lectures

See Attachment A37


See Attachment A37

Other (e.g. unpaid advisory roles) See Attachment A37

None.

See Attachment A37


A/Prof Chris McCormack Lead dermatologist, Peter

MacCallum Cancer Institute;

Lead dermatologist, Caulfield

Dermatology

Consultancy fees/ honorarium Merck – advisory/board

Takeda – advisory/board


Sanofi – Travel to American

Association of Dermatology

Other (e.g. registration, fees for conferences, institutional interests, etc – see policy)

Sanofi – Registration at

American Association of

Dermatology (AADermatol) San

Diego

Publications

See Attachment A27

Expert testimony

Medical advice on skin cancer

None.

Prof Catriona McLean Director, Pathology Board,

Monash University; Director,

Anatomical Pathology, The

Alfred Hospital

None. Publications

See Attachment A28

Speeches/lectures

One skin and cancer talk

None.


A/Prof Catriona McNeil Staff Specialist, Medical

Oncology, Chris O’Brien

Lifehouse and Royal Prince

Alfred Hospital, NSW

Grants

MSD has provided grant

support

Consultancy fees/honorarium MSD: fees directed to my institution

Support for travel or accommodation MSD: support to attend ASCO

in 2015 and speak in New

Zealand and Philippines

Publications

See Attachment A36

Speeches/lectures

See Attachment A36

Development of related materials, including guidelines, standards, educational materials or fact sheets Have developed educational

materials regarding BRAF

inhibitors for our unit

Other (e.g. unpaid advisory roles) Bristol Myers Squibb education

session on toxicity management

None.

A/Prof Alexander Menzies Medical Oncologist, CINSW

Senior Research Fellow,

Melanoma Institute Australia,

Royal North Shore Hospital,

The University of Sydney


Bristol Myers Squibb, MSD,

Novartis, Roche, Pierre Fabre

Support for travel or accommodation ASCO 2017 Bristol Myers

Squibb

Publications

See Attachment A35

Speeches/lectures

See Attachment A35


See Attachment A35

None.

Dr Bill Murray Head of anatomical pathology,

Peter MacCallum Cancer Centre

Dr Jonathan Ng Honorary Research Fellow,

Victorian Melanoma Service,

The Alfred Hospital, VIC;

Dermatologist, Hobart Medical

Specialist, TAS

None. Publications

Ng JC et al. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: Experience of an Australian tertiary referral

None.


service. Arch Dermatol 2010; 146: 234-9.


2008 Melanoma Guidelines NHMRC subcommittee – clinical diagnosis

Prof Omgo Nieweg Surgeon, Melanoma Institute

Australia

None. Publications

Not specified

Speeches/lectures

Not specified

Development of related materials, including guidelines, standards, educational materials or fact sheets Involvement with this present

guidelines.

None.

Dr Shahneen Sandhu Medical oncologist and Clinical

researcher, Peter MacCallum

Cancer Centre


Dr Mark Shackleton Group Leader: Cancer

Development and Treatment

Laboratory; Medical Oncologist,


Centre

Grants

Not specified.

Consultancy fees/honorium

Not specified.

Support for travel or accommodation Not specified.

Meals and beverages Not specified.

Other (e.g. registration for

conferences, institutional

interest, etc – see policy) Not

specified.

Publications

See Attachment A32

Speeches/lectures

See Attachment A32

None.

Dr Saxon Smith Principal Dermatologist in

Private Practice, The

None. Publications

See Attachment A40

None.

Dermatology and Skin Cancer

Centre/LaserCare Dermatology,

Gosford and St Leonards,

NSW; Staff Specialist,

Department of Dermatology,

Royal North Shore Hospital, St

Leonards, NSW; Clinical

Associate Professor, Discipline

of Dermatology, Northern Clinical

School, Sydney Medical

School, University of Sydney,

NSW

Speeches/lectures

See Attachment

A40

advisory

Other (e.g. unpaid

roles) uncil

Assisting Cancer Co ancer

public Australia with skin c on

and awareness informati

website content.

ssociation Australian

Medical A kin cancer (NSW)

creation of s wareness and sun

protection a campaign.


A/Prof Mark (Bernard) Smithers Surgeon, Upper GI, Soft Tissue

Unit, Princess Alexandra

Hospital; Associate Professor,

Department of Surgery, The

University of Queensland

None. Publications

See Attachment

A29

Speeches/lectures

See Attachment

A29

Development of rel ated

materials, includin g

guidelines, standar ds,

educational materi als or fact

sheets

Involvement with thi s present

guidelines developm ent and

with the 2008 guidelines

Relationships

I am a surgeon and I work in a Melanoma unit in a public hospital and I run a private practice that is involved in a large number of patients with melanoma.

Activities

I am actively treating patients

with melanoma – see above.

Mr John Spillane General surgeon, Epworth

Eastern Consulting

None. Publications

See Attachment

A30

Speeches/lectures

See Attachment

A30

Development of rel

materials, includin ated

guidelines, standar g

educational materi ds,

sheets als or fact

None.

See Attachment A30

A/Prof Jonathan Stretch AM Plastic surgeon and Deputy

Director, Melanoma Institute Australia; Associate Professor of Melanoma and Skin Oncology, The University of Sydney

None. Publications

Speeches/lectures

See Attachment

A33

See Attachment

A33

None.


Development of rel ated

materials, includin g

guidelines, standar ds,

educational materi als or fact

sheets

See Attachment A33

Dr Geoffrey (Geoff) Strutton Anatomical Pathologist,


None. None. None.

Prof David Whiteman Senior Principal Research

Fellow and Head, Cancer

Control Group, Queensland

Institute of Medical Research

(QIMR) Berghofer Medical

Research Institute

Support for travel or accommodation Invited speaker to Australian

Melanoma Congress 2016 and

World Congress of Melanoma

2017

Other (e.g. registration fees for conferences, institutional interests etc – see policy) Invited speaker to Australian Melanoma Congress 2016 and

World Congress of Melanoma

2017

Publications

Not specified.

Speeches/lectures

Invited speaker to A

Melanoma Congres ustralian

World Congress of s 2016 and

2017 Melanoma

Development of rel

materials, includin ated

guidelines, standar g

educational materi ds,

sheets als or fact

Melanoma guideline

s 2018

Other (e.g. unpaid

roles) advisory

Advice to Cancer C

various public health

ouncil’s

committees

Relationships

Employee of QIMR Berghofer Medical Research Institute, which derives philanthropic donations for the purpose of conducting research into

melanoma

Activities

Convenor of the Sunscreen

Summit 2018

Dr Gabrielle Williams Researcher, University of

Sydney, The Children's Hospital

at Westmead and Melanoma

Institute Australia

None. None. None.

●

●

30

Documents

Conflict of interest register: Clinical Practice ... · Last updated: June 2018. Page 1 Conflict of interest register: Clinical Practice Guidelines for the Diagnosis and Management